Prime Medicine, Inc. (PRME )
Currency in USD Disclaimer
Subscribe Now for Delta3 AI Alerts
Don’t miss out on top stock picks and market insights. Subscribe to Delta3 AI Alerts for real-time updates and expert analysis straight to your inbox. Stay informed and maximize your investment potential.
Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
- Symbol PRME
- Company Prime Medicine, Inc.
- Price $4.72
- Changes Percentage -9.92
- Change -0.52
- Day Low $4.68
- Day High $5.2
- Year High $6.94
- Year Low $2.67
- Market Cap $554,495,572
- Price Avg 50 EMA (D) $3.24
- Price Avg 200 EMA (D) $3.52
- Exchange NASDAQ
- Volume 3,962,905
- Average Volume 3,258,052
- Open $5.01
- Previous Close $5.24
- EPS -1.06
- PE -2.90
- Earnings Announcement 2026-11-06 05:00:00
- Shares Outstanding $180,617,450
Company brief: PRIME MEDICINE, INC. (PRME )
- Healthcare
- Biotechnology
- Dr. Keith Michael Gottesdiener M.D., Ph.D.
- https://www.primemedicine.com
- US
- N/A
- 10-20-2022
- US74168J1016
Prime Medicine, Inc., a biotechnology company, delivers genetic therapies to address diseases by deploying gene editing technology. It offers Prime Editors with a Prime Editor protein, comprising a fusion between a Cas protein and a reverse transcriptase enzyme; and a pegRNA, which targets the Prime Editor to a specific genomic location and provides a template for making the desired edit to the target DNA sequence. The company was incorporated in 2019 and is headquartered in Cambridge, Massachusetts.